| Phytochemical Name : Estrone |
| PCNDIDE0072 |
| Pubchem CID : 5870 |
| Molecular formula: C18H22O2 |
| Canonical SMILES : CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O |
Synonymes : estrone|53-16-7|folliculin|OESTRONE|Theelin|Thelykinin|Ketohydroxyestrin|estrovarin|Estrugenone|Kestrone|Estron|Tokokin|Aquacrine|Disynformon|Folliculine|Follicunodis|Glandubolin|Hiestrone|Hormestrin|Oestroform|Oestronum|Oestroperos|Destrone|Femidyn|Folipex|Folisan|Menagen|Oestrin|Kolpon|Unden|Estrone-A|Ketohydroxyoestrin|Cristallovar|Endofolliculina|Crinovaryl|Crystogen|Estrusol|Folikrin|Follestrine|Follestrol|Hormofollin|Hormovarine|Ketodestrin|Menformon|Mestronaq|Ovifollin|Perlatan|Solliculin|Thelestrin|Thynestron|Wynestron|3-Hydroxyestra-1,3,5(10)-trien-17-one|Ketohydroxy-Estratriene|Femestrone injection|Folliculine benzoate|Estrogenic Substance|1,3,5(10)-Estratrien-3-ol-17-one|Ovex (tablets)|estrol|Estrona|Estrona [Spanish]|Fem-O-Gen|Estronum [INN-Latin]|Estrona [INN-Spanish]|Estronum|Unden (pharmaceutical)|Estra-1,3,5(10)-trien-17-one, 3-hydroxy-|E(sub 1)|3-Hydroxy-17-keto-estra-1,3,5-triene|hydroxyestrones|Folliculinum|3-Hydroxy-oestra-1,3,5(10)-trien-17-one|Estrone [USAN:INN]|1,3,5(10)-Oestratrien-3-ol-17-one|3-Hydroxy-17-keto-oestra-1,3,5-triene|delta-1,3,5-Estratrien-3beta-ol-17-one|delta-1,3,5-Oestratrien-3beta-ol-17-one|delta-1,3,5-estratrien-3-beta-ol-17-one|3-Hydroxyestra-1,3,5(10)-triene-17-one|delta-1,3,5-oestratrien-3-beta-ol-17-one|(+)-Estrone|Estrone (E1)|CCRIS 285|(+/-)-Oestrone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Unden (pharmaceutical) (VAN)|(+/-)-Estrone|Aquest|Estradiol metabolite e1|Oestrone [Steroidal oestrogens]|Estrone DL-form [MI]|HSDB 3324|Estrone, (+/-)-|NATURAL ESTROGENIC SUBSTANCE-ESTRONE|1,3,5-Estratrien-3-ol-17-one|NSC 9699|(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one|19973-76-3|EINECS 200-164-5|UNII-2DI9HA706A|Estrone (TN)|BRN 1915077|2DI9HA706A|DTXSID4022367|CHEBI:17263|3-hydroxy-estra-1,3,5(10)-trien-17-one|NSC-9699|WAY 164397|Estrone (JAN/USP/INN)|Estrone [USP:INN:BAN]|CHEMBL1405|UNII-X9XKA379T9|Fermidyn|Estrin|MLS000028475|DTXCID402367|Femestrone inj.|X9XKA379T9|EC 200-164-5|3-08-00-01171 (Beilstein Handbook Reference)|CMC_13458|Estra-1,3,5(10)-trien-17-one, 3-hydroxy-, (+/-)-|SMR000058338|3-hydroxyl-1,3,5(10)-estratien-17-one|ESTRONE (MART.)|ESTRONE [MART.]|E0026|ESTRONE (USP-RS)|ESTRONE [USP-RS]|E 9750|(13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one|[2,4,6,7-3H]-E1|ESTRONE (USP MONOGRAPH)|ESTRONE [USP MONOGRAPH]|NSC9699|(9beta,13alpha)-3-Hydroxyestra-1,3,5(10)-Trien-17-One|Unigen|Wehgen|Follidrin (tablets)|Ketophydroxyestrin|WynestronPencap M|(8R,9S,13S,14S)-3-HYDROXY-13-METHYL-6,7,8,9,11,12,13,14,15,16-DECAHYDRO-17H-CYCLOPENTA(A)PHENANTHREN-17-ONE|(8R,9S,13S,14S)-3-hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17H-cyclopenta[a]phenanthren-17-one|ETHINYLESTRADIOL IMPURITY C (EP IMPURITY)|ETHINYLESTRADIOL IMPURITY C [EP IMPURITY]|Estrone, (+-)-Isomer|ESTRADIOL HEMIHYDRATE IMPURITY A (EP IMPURITY)|ESTRADIOL HEMIHYDRATE IMPURITY A [EP IMPURITY]|Estrone, (9 beta)-Isomer|oestron|Estrone, (8 alpha)-Isomer|1,3,5-Oestratrien-3-ol-17-one|estron-|Oestrone, Estrone|CAS-53-16-7|NCGC00015423-03|Therapeutic Estrone|J3Z|Hauck Brand of Estrone|Hyrex Brand of Estrone|ESTRONE [VANDF]|Opera_ID_330|ESTRONE [HSDB]|Estrone, >=99%|ESTRONE [INN]|ESTRONE [JAN]|ESTRONE [MI]|Vortech Brand of Estrone|Prestwick0_000914|Prestwick1_000914|Prestwick2_000914|Prestwick3_000914|Spectrum5_002047|ESTRONE [WHO-DD]|bmse000549|D00ZFP|FOLLICULINUM [HPUS]|Lopac0_000513|SCHEMBL21702|BSPBio_000788|MLS001077340|MLS002695951|MLS006011890|BIDD:ER0145|ESTRONE [ORANGE BOOK]|SPBio_002977|BPBio1_000868|GTPL2818|MEGxm0_000444|SGCUT00128|Estrone 1.0 mg/ml in Methanol|ACon0_000083|ACon1_000122|BDBM17289|[2,4,6,7-3H]-Estrone|G03CA07|G03CC04|HMS1570H10|HMS2090E22|HMS2097H10|HMS2232O15|HMS3261H07|HMS3714H10|BCP13336|HY-B0234|to_000049|Tox21_113567|Tox21_201375|Tox21_303651|Tox21_500513|BBL033470|BL-090|LMST02010004|s1665|STK801833|AKOS005622512|AKOS007930641|Tox21_113567_1|AC-1395|CCG-204604|DB00655|DS-6316|Estrone 100 microg/mL in Acetonitrile|LP00513|SDCCGSBI-0050497.P002|SMP1_000123|NCGC00023643-03|NCGC00023643-04|NCGC00023643-05|NCGC00023643-06|NCGC00023643-07|NCGC00023643-08|NCGC00023643-09|NCGC00023643-10|NCGC00023643-11|NCGC00023643-12|NCGC00023643-13|NCGC00023643-15|NCGC00023643-16|NCGC00023643-22|NCGC00179433-01|NCGC00179433-02|NCGC00179433-03|NCGC00257402-01|NCGC00258926-01|NCGC00261198-01|Estrone, meets USP testing specifications|LS-64884|D1,3,5(10)-Estratrien-3-ol-17-one|3-Hydroxyoestra-1,3,5(10)-trien-17-one|AB00382990|Estrone, VETRANAL(TM), analytical standard|EU-0100513|3-hydroxy-estra-1,3,5(10)-triene-17-one|C00468|D00067|EN300-120636|AB00382990-16|AB00382990-17|AB00382990_18|estra-1(10),2,4-trien-17-one, 3-hydroxy-|Q414986|SR-01000000085|SR-01000075867|Estra-1, 3,5 (10)-trien-17-ona, 3-hidroxi-|Q-201073|SR-01000000085-3|SR-01000075867-1|BRD-K81839095-001-04-6|BRD-K81839095-001-30-1|86C77018-146D-4603-ACEA-CA0D8C4F1E2C|Estrone, European Pharmacopoeia (EP) Reference Standard|Z1530425070|Estrone, United States Pharmacopeia (USP) Reference Standard|Estrone, Pharmaceutical Secondary Standard; Certified Reference Material|(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-2,4,6-trien-14-one|(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one|(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-one|(8R,13S)-3-Hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one |
| Structure | |
| 3D structure | 2D structure |
![]() |
| Log Po/w (iLOGP) : 2.400 |
| Log Po/w (XLOGP3) : 3.130 |
| Log Po/w (WLOGP) : 3.820 |
| Log Po/w (MLOGP) : 3.440 |
| Log Po/w (SILICOS-IT) : 3.840 |
| Consensus Log Po/w : 3.330 |

